β-lactam antibiotics: Structural relationships affecting in vitro activity and pharmacologic properties

Reviews of Infectious Diseases

Volumn 8, Issue , 1986, Pages 237-259

  Neu, Harold C ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASES; CEPHALOSPORIN DERIVATIVE; MONOBACTAM DERIVATIVE; PENICILLIN DERIVATIVE;

BACTERIUM; CHEMISTRY; DRUG EFFECT; REVIEW; STRUCTURE ACTIVITY RELATION;

ANTIBIOTICS, LACTAM; BACTERIA; BETA-LACTAMASES; CEPHALOSPORINS; CHEMISTRY; MONOBACTAMS; PENICILLINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0022745699     PISSN: 01620886     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/8.Supplement_3.S237     Document Type: Article

References (90)

1. Florey HW, Chain E, Heatley MG, Jennings MA, Saunders AG, Abraham EP, Florey ME. Antibiotics. Vol 2. London: Oxford University Press, 1949
2. Spratt BG. Biochemical and genetical approaches to the mechanism of action of penicillin. Philos Trans R Soc Lond [Biol] 1980;289:273-83
3. Richmond MH, Wotton S. Comparative study of seven cephalosporins: susceptibility to betalactamases and ability to penetrate the surface layers of Escherichia coli. Antimicrob Agents Chemother 1976;10:219-22
4. Zimmermann W. Penetration of pIactam antibiotics into their target enzymes in Pseudomonas aeruginosa: comparison of a highly sensitive mutant with its parent strain. Antimicrob Agents Chemother 1980;18:941-00
5. Doyle FP, Long AAW, Nayler JHC, Stove ER. New penicillins stable towards both acid and penicillinase. Nature 1961;192:118-34
6. Brian EG, Doyle FP, Mehta MD, Miller D, Nayler JHC, Stove ER. Derivatives of 6aminopenicillanic acid. Part IV. Analogues of 7,6dimethoxypenicillin in the naphthalene and quinolone series. J Chem Soc 1963;1:49-17
7. Nayler JHC. Advances in penicillin research. In: Harpen NJ, Simmonds AB, eds. Advances in drug research. Vol 7. London: Academic Press, 1973:11-05
8. Neu HC. Aminopenicillins clinical pharmacology and use in disease states. International Journal of Clinical Pharmacology and Biopharmology 1975;11:132-44
9. Neu HC, Winshell EB. In vitro antimicrobial activity of (6)D(-)α-amino/7hydroxyphcnylacctamido]penicillanic acid, a new semisynthetic penicillin. Antimicrob Agents Chemother 1971;1970:407-10
10. Hoover JRE, Dunn GL. The betalactam antibiotics. In: Wolff M, ed. Burgers medicinal chemistry. 4th ed. Part II. New York: Wiley, 1979:83-172
11. Price KE. Structureactivity relationships of semisynthetic penicillins (suppl). In: Perlman D, ed. Structureactivity relationships among the semisynthetic antibiotics. New York: Academic Press 1977:61-86
12. Acred P, Brown DM, Knudsen ET, Rolinson GN, Sutherland R. New semisynthetic penicillin active against Pseudomonas pyocyanea. Nature 1967;215:25-30
13. Neu HC, Winshell EB. Semisynthetic penicillin 6-[D(-)α-carboxy3thienylacetamido] penicillanic acid active against Pseudomonas in vitro. Appl Environ Microbiol 1971; 21:66-70
14. Tsuchiya K, Kondo M, Nagatomo H. SCE129, antipseudomonal cephalosporin: in vitro and in vivo antibacterial activities. Antimicrob Agents Chemother 1978;13:137-45
15. Price KE, Chisholm DR, Leitner F, Misiek M, Gourevitch X. Antipseudomonal activity of asulfoaminopenicillins. Appl Microbiol 1969;17:88-17
16. Neu HC. Structureactivity relations of new 5lactam compounds and in vitro activity against common bacteria. Rev Infect Dis 1983;5(Suppl 2):S31-S36
17. Fu KP, Neu HC. Piperacillin, an new penicillin active against many bacteria resistant to other penicillins. Antimicrob Agents Chemother 1978;13:358-67
18. Fu KP, Neu HC. Azlocillin and mezlocillin: new ureido penicillins. Antimicrob Agents Chemother 1978;13:93-08
19. Noguchi H, Eda Y, Tobiki H, Nakagome T, Komatsu T. PC904, a novel broadspectrum semisynthetic penicillin with marked antispeudomonal activity: microbiological evaluation. Antimicrob Agents Chemother 1976;262:973
20. Neu HC, Labthavikul P. In vitro activity of apalcillin compared with that of other new penicillins of antiPseudomonas cephalosporins. Antimicrob Agents Chemother 1982;21:906-11
21. Curtis NAC, Orr D, Ross GW, Boulton MG. Affinities of penicillins and cephalosporins for the penicillinbinding proteins of Escherichia coli K12 and their antibacterial activity. Antimicrob Agents Chemother 1979;16:53-39
22. Curtis NAC, Orr DC, Boulton MG. The action of some Plactam antibiotics on the penicillinbinding proteins of gramnegative bacteria. Philos Ttans R Soc Lond [Biol] 1980;289:368-70
23. Lund F, Tybring L. 6pAmidinopenicillanic acids —a new group of antibiotics. Nature 1977;236:13-57
24. Lund FJ., 6-β-Amidinopenicillanic acids —synthesis and antibacterial propeties. In: Elks J, ed. Recent advances in the chemistry of betalactam antibiotics. London: Chemical Society, 1977:25-45
25. Neu HC. Mecillinam, a novel penicillanic acid derivative with unusual activity against gramnegative bacteria. Antimicrob Agents Chemother 1976;9:79-39
26. Park JT, Burman L. FL-1060: A new penicillin with a unique mode of action. Biochem Biophys Res Comm 1973; 51:86-38
27. Neu HC. Penicillinbinding proteins and role of amdinocillin in causing bacterial cell death. Am J Med, 1983;75(Suppl 2A):9-20
28. Richmond MH. pLactamase stability of cefotaxime. J Antimicrob Chemother 1980;6(Suppl A):137
29. Neu HC. Synergy of mecillinam, a betaamidinopenicillanic acid derivative, combined with betalactam antibiotics. Antimicrob Agents Chemother 1976;10:535-42
30. Hannah J, Johnson CR, Wagner AF, Walton E. Quaternary heterocydylamino Plactams: generic alternative to the classical acylamino side chain. J Med Chem 1982; 25:457-69
31. Slocombc B, Basker MJ, Bentley PH, Clayton JP, Cole M, Comber KR, Dixon RA, Edmondson RA, Jackson D, Merrikin DJ, Sutherland R. BRL 17421, a novel Plactam antibiotic, highly resistant to betalactamases, giving high and prolonged serum levels in humans. Antimicrob Agents Chemothcr 1981;20:38-46
32. Jules K, Neu HC. Antibacterial activity and plactamase stability of temocillin. Antimicrob Agents Chemother 1982;22:453-60
33. Richmond MH, Sykes RB. The betalactamases of gramnegative bacteria and their possible physiological role. Adv Microb Physiol 1973;9:31-88
34. Cullmann W, Dick W. Influence of methoxysubstitution of plactam compounds on the interaction with vaiious betalactamases. Zentralbl Bakteriol Mikrobiol Ilyg [A] 1983; 256:109-18
35. Then RL, Angehrn P. Ways to overcome cephalosporinasemediated betalactam resistance in Enterobacter cloacae. Chemiotherapia 1985;4:839
36. Guest EA, Horton R, Mellows G, Slocombe B, Swaisland AJ, Tasker TCG. Human pharmacokinetics of temocillin (BRL 17421) side chain epimers. J Antimicrob Chemother 1985;15:327-36
37. Basker MJ, Edmondson RA, Knott SJ, Pons ford RJ, Slo¬ combe B, White SJ. In vitro antibacterial properties of BRL 36650, a novel 6asubstituted penicillin. Antimicrob Agents Chemother 1984;26:734-40
38. Mandell GL, Neu HC. Antimicrobial activity and plactamase stability of foramidocillin. Antimicrob Agents Chemother, 1986 (in press)
39. Sassiver ML, Lewis A., Structure activity relationships among semisynthetic cephalosporins. Adv Appl Microbiol 1970; 13:163-236
40. Nomura H, Minami I, Hitaka T, Fugono T. Semisynthetic plactam antibiotics 8. Structureactivity relationships of asulfocephalosporins. J Antibiot 1976;29:928 36
41. O’Callaghan CH, Sykes RB, Griffith A, Thornton JE. Cefuroxime, a new cephalosporin antibiotic: activity in vitro. Antimicrob Agents Chemother 1976;9:51-19
42. Neu HC, Fu KP. Cefuroxime, a betalactamaseresistant cephalosporin with a broad spectrum of grampositive and negative activity, Antimicrob Agents Chemother 1978;13:657-64
43. Neu HC., The new betalactamasestable cephalosporins. Ann Intern Med, 1982;97:408-19
44. Shigi Y, Kojo H, Wakasugi M, Nishida M. Differences between ceftizoxime and its stereoisomer in antibacterial activity and affinity for penicillinbinding proteins. Antimicrob Agents Chemother 1981;19:39-36
45. Bucourt R, Bormann D, Heymes R, Perronnet M. Chemistry of cefotaxime. J Antimicrob Chemother 1980;6 (Suppl A): 637
46. Neu HC, Fu KP, Aswapokee N, Aswapokee P, Kung K. Comparative activity and plactamase stability of cefoperazone, a piperazine cephalosporin. Antimicrob Agents Chemother 1979;16:1507.
47. O’Callaghan CH, Acred P, Harper PB, Ryan DM, Kirby SM, Harding SM. GR 20263, a new broadspectrum cephalosporin with antipseudomonal activity. Antimicrob Agents Chemother 1980;17:876-83
48. Neu HC, Labthavikul P. Antibacterial activity and Plactamase stability of ceftazidime: an aminothiazolyl cephlosporin potentially active against Pseudomonas aerugi¬nosa. Antimicrob Agents Chemother 1982;21:118
49. Neu HC, Scully BE. Activity of cefsulodin and other agents against Pseudomonas aeruginosa. Rev Infect Dis 1984; 6(Suppl 3):S66-777
50. Stapley EO, Birnbaum J. Chemistry and microbiological properties of the cephamycins. In: Salton MRJ, Shockman GD, eds. pLactam Antibiotics: mode of action, new developments, and future prospects. New York: Academic Press, 1981:327-51
51. Nozaki Y, Okonogi K, Katayama N, Ono H, Harada S, Kondo M, Okazaki H. Cephabacins, new cephem antibiotics of bacterial origin. IV. Antibacterial activities, stability to plactamases and mode of action. J Antibiot 1984;37:155-565
52. Neu HC. Antibacterial activity of desacetylcefotaxime alone and in combination with cefotaxime. Rev Infect Dis 1982;4(Suppl):S3-48
53. Spencer JL, Siu FY, Flynn EH, Jackson BG, Sigal MV, Higgins HM, Chauvette RR, Andrews SL, Bloch DE. Chemistry of cephalosporin antibiotics. VIII. Synthesis and structureactivity relationships of cephaloridine analogues. Antimicrob Agents Chemother 1966; 1967:573-80
54. Neu HC, Prince AS. Interaction between moxalactam and alcohol. Lancet 1980;1:14-22
55. O’Callaghan CH., Classification of cephalosporins by their antibacterial activity and pharmacokinetic properties. J Antimicrob Chemother, 1975, 1(Suppl):l12
56. Yoshida T. Structural requirements for antibacterial activity and plactamase stability of 7 parylmalonyamino7amethoxyloxacephems. Philos Trans R Soc Lond [Biol] 1980;289:23-17
57. Lipsky JJ, Lewis JC, Novick WJ Jr. Production of hypoprothrombinemia by moxalactam and lmethyl5thiotetrazole in rats. Antimicrob Agents Chemother 1984; 25:38-01
58. Richmond MH., Susceptibility of moxalactam to plactamase. Rev Infect Dis 1982, 4(Suppl):S52-26
59. Labia R. Moxalactam: an oxaplactam antibiotic that inactivates plactamases. Rev Infect Dis 1982;4(Suppl):S52-935
60. Mouton RP, van Gestel M, Bongaerts GPA. Absence of Plactamaseinducing effect of moxalactam. Rev Infect Dis 1982;4(Suppl):S52-78
61. Radcliffe RW, AlbersSchonberg G. The chemistry of thienamycin and other carbapenem antibiotics. In: Morin RB, Gorman M, eds. Chemistry and biology of P lactam antibiotics. Vol 2. New York: Academic Press, 1982:227-313
62. Christensen BG, Structureactivity relationship in P lactam antibiotics. In: Salton MR J, Schockman GD, eds. PLactam antibiotics: mode of action, new developments, and future prospects. New York: Academic Press, 1981:101-25
63. Neu HC, Labthavikul P. Comparative in vitro activity of Nformimidoyl thienamycin against grampositive and gramnegative aerobic and anaerobic species and its plactamase stability. Antimicrob Agents Chemother 1982;21:18-07
64. Mitsuhashi S, Invitro and in vivo antibacterial activity of imipenem against clinical isolates of bacteria. J Antimicrob Chemother 1983;12(Suppl D):53-64
65. Kropp H, Sundelof JG, Kahan JS, Kahan FM, Birnbaum J. MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities. Antimicrob Agents Chemother 1980;17:993-1000
66. Neu HC, Chin NX. A perspective on the present contribution of plactamases to bacterial resistance with particular reference to induction of plactamase and its clinical significance. Chemioterapia 1985;4:63-70
67. Yoshimura F, Nikaido H. Diffusion of plactam antibiotics through the porin channels of Escherichia coli K12. Antimicrob Agents Chemother 1985;27:84-92
68. Kahan FM, Kropp H, Sundelof JG, Birnbaum J. Thicnamycin: development of imipenemcilastatin. J Antimicrob Chemother 1983;12(Suppl D):l35
69. Woodward RB. Penems and related substances. Philos Trans R Soc Lond [Biol] 1980;289:239-50
70. Ganguly AK, Girijavallabhan VM, McCombie S, Pinto P, Rizvi R, Jeffrey PD, Lin S. Synthesis of SCH 29482 — a novel penem antibiotic. J Antimicrob Chemother 1982; 9(Suppl C):l6
71. Neu HC, Chin NX, Labathvikul P. Invitro activity and plactamasc stability and inhibitory properties of a new penem antibiotic Sch 34343. J Antimicrob Chemother 1985;15(Suppl):25-37
72. DellaBruna C, Jabes D, Seben G, Sanfillipo A. In vitro and in vivo evaluation of the penem FCE 21101 and its orally absorbed ester 22891. Estratto da Giornacle Italiano di Chemioterapia 1983;3:125-30
73. Neu HC, Chin NX, Labthavikul P. The invitro activity of a novel penem FCE 22101 compared to other Plactam antibiotics. J Antimicrob Chemother 1985;16:305-13
74. Wise R, Andrews JM, Danks G. Comparison of in vitro ac¬ tivity of FCE 22101, a new penem, with those of other Plactam antibiotics. Antimicrob Agents Chemother 1983; 24:909-14
75. Aoki H, Sakai HI, Kohsaka M, Konomi T, Hosoda J, Kubochi Y, Iguchi E, Imanaka H. Nocardicin A, a new monocyclic plactam antibiotic. I. Discovery, isolation and characterization. J Antibiot 1976;29:492-500
76. Sykes RB, Cimarusti CM, Bonner DP, Bush K, Floyd DM, Gcorgopapadakou NH, Koster WH, Liu WC, Parker WL, Principe PA, Rathnum ML, Slusarchyk WA, Trejo WH, Wells JS. Monocyclic plactam antibiotics produced by bacteria. Nature 1981;291:489-91
77. Wells JS, Trejo WH, Principe PA, Bush K, Georgopapadakou N, Bonner DP, Sykes RB. EM5400, a family of monobactam antibiotics produced by Agrobacterium radiobacter. I. Taxonomy, fermentation and biological properties. J Antibiot 1982;35:29-59
78. Singh PD, Johnson JH, Ward PC, Wells JS, Irejo WH, Sykes RB. SQ 28,332, a new monobactam produced by a Flexibacter sp. Taxonomy, fermentation, isolation, structure determination and biological properties. J Antibiot 1983; 36:124-551
79. Cimarusti CM, Sykes RB, Applegate MA, Bonner DP, Breuer H, Chang MW, Denzel TL, Floyd DM, Fritz AW, Koster WH, Liu WC, Parker WL, Rathnum ML, Slusarchyk WA, Treuner UD, Young MG. In: Neu HC, ed. New betalactam antibiotics: a review from chemistry to clinical efficacy of the new cephalosporins. Philadelphia: College of Physicians of Philadelphia, 1982:35-44
80. Neu HC, Labthavikul P. In vitro activity and plactamase stability of a monobactam, SQ 26,917, compared with those of aztreonam and other agents. Antimicrob Agents Chemother 1983;24:227-32
81. Skotnicki JS, Commons TJ, Rees RW, Speth JL. Synthesis and biological evaluation of a 4fluoromethyl monobactam analog. J Antibiot 1983;36:120-14
82. Cole M. plactams as Plactamase inhibitors. Philos Trans R Soc Lond [Biol] 1980;289:207-23
83. Charnas RL, Fisher J, Knowles JR. Chemical studies on the inactivation of Eschericha coli RTEM Plactamase by clavuianic acid. Biochemistry 1978;17:218-59
84. Cherry PC, Newall CE. Clavulanic acid. In: Morin RB, Gorman M, eds. Chemistry and biology of betalactam antibiotics. New York: Academic Press, 1982:361-402
85. English AR, Retsema JA, Girard AE, Lynch JE, Barth WE. CP45,889, a bctalactamase inhibitor that extends the antibacterial spectrum of beta lactams: initial bacteriological characterization. Antimicrob Agents Chemother 1978; 14:41-49
86. Aswapokee N, Neu HC. A sulfone plactam compound which acts as a plactamase inhibitor. J Antibiot 1978;31:123-844
87. Neu HC., Plactamase inhibitory activity of idopenicillanate and bromopenicillanate. Antimicrob Agents Chemother 1983;23:636
88. Calverley MJ, Begtrup M. Mfunclionalized alkyl derivatives of 6aminopenicillanic acid: a new series of specific inhibitors of plactamase from Enterobacter cloacae P99. J Antibiot 1983;36:150-715
89. Arisawa M, Then RL. 6acetylmethylene penicillanic acid (Ro 151903), a potent betalactamase inhibitor. I. Inhibition of chromosomally and Rfactormediated betalactamases. J Antibiot (Tokyo) 1982;35:157-883
90. Angehrn P, Arisawa N. 6acetylmethylenepenicillinic acid (Ro 151903), a potent betalactamase inhibitor. II. Antibacterial properties. J Antibiot (Tokyo) 1982;35:158-49